lobbying_activities
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
901 rows where filing_year = 2012 and issue_code = "PHA" sorted by filing_year descending
This data as json, CSV (advanced)
Suggested facets: filing_type, is_termination, received_date (date)
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year ▲ | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1222689 | UNIVERSITY OF IOWA 8b9cb3b0-199e-49de-a24f-ac185760a0b2 | Q1 | UNIVERSITY OF IOWA | 49191 | UNIVERSITY OF IOWA | 2012 | first_quarter | PHA | Increased appropriations for systems to shorten the time between development of a drug and its release to the public FDA reform as it relates to drug development and research Collaborative research on drug development anti-malarial pharmaceuticals FY 2011 Agricultural Appropriations human factors research related to neuropharmaceuticals | Agriculture, Dept of (USDA),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Emergency Management Agency (FEMA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE,State, Dept of (DOS),Transportation, Dept of (DOT) | 88684 | 0 | 0 | 2012-04-02T10:31:37.897000-04:00 | |
| 1223235 | SHELTER ROCK STRATEGIES, LLC 044ff090-63c8-44fd-9081-604de09fed62 | Q1 | SHELTER ROCK STRATEGIES, LLC | 400772326 | NEW YORK MEDICAL COLLEGE | 2012 | first_quarter | PHA | BARDA Solicitation HHS 11-100SOL-00011, Centers for Innovation in Advanced Development and Manufacturing, Assess the likelihood this solicitation will get funded, assess competition, assist in writing and getting signed memoranda of support from the NY Congressional Delegation, and assist in obtaining support from NY State to aid the client's proposal. | HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2012-04-03T15:00:32.147000-04:00 | |
| 1223524 | JONES PUBLIC AFFAIRS, INC. d76e8fa1-cc7f-424d-b48f-1373ac9613b4 | Q1 | JONES PUBLIC AFFAIRS, INC. | 400738211 | THE SAFDAR GROUP (ON BEHALF OF THE PARTNERSHIP FOR SAFE MEDICINES) | 2012 | first_quarter | PHA | Protecting patients and consumers from counterfeit, substandard and otherwise unsafe medications | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2012-04-05T09:21:50.120000-04:00 | |
| 1223887 | INDEPENDENT PHARMACY COOPERATIVE 53525802-ccf5-4bd7-873a-076533ddf8f2 | Q1 | INDEPENDENT PHARMACY COOPERATIVE | 313098 | INDEPENDENT PHARMACY COOPERATIVE | 2012 | first_quarter | PHA | CMS Average Manufacturer Price (AMP) Final Rule. Reporting by manufacturers and calculation. S. 1002 SAFE DOSES ACT of 2011. All provisions. Potential prescription drug track-and-trace legislation. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2012-04-06T13:35:10.240000-04:00 | |
| 1223965 | CYBER SECURITY RESEARCH CONSULTANTS, LLC 554643a1-e661-4595-8d7d-a1f1bf1d2e22 | Q1 | CYBER SECURITY RESEARCH CONSULTANTS, LLC | 91694 | PDFRAZER CONSULTING INC CANADIAN INTERNATIONAL PHARMACY ASSOCIATION | 2012 | first_quarter | PHA | Food and Drug Safety Globalization Act Monitoring Dorgan-Snowe Drug Reimportation from Canada Monitoring Protect IP Act, Monitoring SOPA Monitoring FDA Reauthorization Act | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2012-04-08T16:50:43.043000-04:00 | |
| 1224486 | VENABLE LLP 0bca596b-8999-4965-bbd8-41bcf1f0b1c9 | Q1 | VENABLE LLP | 39941 | ENDO PHARMACEUTICALS INC | 2012 | first_quarter | PHA | General issues affecting the pharmaceutical industry and bioequivelence. (Generic pharmaceutical user fee act.) The Life Sciences Investment Act (S. 1410; H.R. 2632) | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2012-04-10T13:20:40.280000-04:00 | |
| 1224774 | INJURED WORKERS PHARMACY 446d8bf4-d5e6-4f5f-87af-fe6040645c83 | Q1 | INJURED WORKERS PHARMACY | 400765309 | INJURED WORKERS PHARMACY | 2012 | first_quarter | PHA | Transparency of Pharmacy Benefit Mangers (bill sponsored by Rep. McMorris-Rodgers and Senator Mark Pryor); Longshore and Harbor Workers Amendement Act of 2011 sponsored by Senator Isakson. | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2012-04-11T09:13:05.413000-04:00 | ||
| 1224830 | R.G. FLIPPO AND ASSOCIATES, INC dfe65896-6be5-4a3e-b253-c5830193a4a5 | Q1 | R.G. FLIPPO AND ASSOCIATES, INC | 14861 | ALABAMA NURSING HOME ASSOCIATION | 2012 | first_quarter | PHA | S. 1560 Nursing Homes Resident Pain Relief Act-all provisions | HOUSE OF REPRESENTATIVES,SENATE | 18000 | 0 | 0 | 2012-04-11T10:08:30.047000-04:00 | |
| 1224908 | RED+BLUE STRATEGIES b3de1807-63b0-4f7f-9043-86e05ccb5555 | Q1 | RED+BLUE STRATEGIES | 400693064 | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) | 2012 | first_quarter | PHA | H.R. 1946 - Preserving Our Hometown Independent Pharmacies Act of 2011, which allows for an antitrust exception for certain pharmacies. Issues related to the practice of giving coupons for certain prescription medications. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2012-04-11T11:20:09.567000-04:00 | |
| 1224928 | AMERICAN COLLEGE OF CLINICAL PHARMACY 64b5a2ef-9c82-476d-a6a4-944a186f598f | Q1 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 57258 | AMERICAN COLLEGE OF CLINICAL PHARMACY | 2012 | first_quarter | PHA | Coverage for direct patient care services of qualified pharmacists under Medicare and other public health programs. | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 61700 | 0 | 0 | 2012-04-11T11:31:16.407000-04:00 | |
| 1225078 | PARRY, ROMANI, DECONCINI & SYMMS 6ccf28a6-af12-44f0-816f-a43df84b26f1 | Q1 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | BRAIDWOOD MANAGEMENT, INC. | 2012 | first_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2012-04-11T14:35:38.287000-04:00 | |
| 1225087 | PARRY, ROMANI, DECONCINI & SYMMS 49e4e169-62c5-4c82-85b4-f76ce34d1f62 | Q1 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | DIAMONDBACK DRUGS | 2012 | first_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation has been introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 6000 | 0 | 0 | 2012-04-11T14:47:43.123000-04:00 | |
| 1225108 | PARRY, ROMANI, DECONCINI & SYMMS 05fb58da-d0d3-402d-bc76-db5c4d9fab98 | Q1 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | VETERINARY PHARMACIES OF AMERICA, INC. | 2012 | first_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2012-04-11T15:11:54.920000-04:00 | |
| 1225141 | PARRY, ROMANI, DECONCINI & SYMMS 9b0d85c7-824e-42d4-8368-023a48f021d7 | Q1 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | WEDGEWOOD VILLAGE PHARMACY, INC. | 2012 | first_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation has been introduced yet. Regulatory issues involving compounded 17P and compounded Avastin. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2012-04-11T15:40:17.113000-04:00 | |
| 1225149 | PARRY, ROMANI, DECONCINI & SYMMS d7ddb76b-e396-4a4b-9476-e413f0eb9bf0 | Q1 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | WOMEN'S INTERNATIONAL PHARMACY, INC. | 2012 | first_quarter | PHA | Issues related to the compounding pharmacies, in particular relating to FDA action to ban the hormone estriol from compounded estrogens. No specific legislation introduced yet. Legislation affecting the operation of compounding pharmacies and the availability of compounded medications. No specific legislation introduced yet. Regulatory issues involving compounded 17P. | HOUSE OF REPRESENTATIVES,SENATE | 11250 | 0 | 0 | 2012-04-11T15:52:23.123000-04:00 | |
| 1225192 | RED+BLUE STRATEGIES f1addf39-bef3-4e58-9e66-ae4e58f2fbf0 | Q1 | RED+BLUE STRATEGIES | 400693064 | EXPRESS SCRIPTS INC. | 2012 | first_quarter | PHA | H.R. 1946 - Preserving Our Hometown Independent Pharmacies Act of 2011, which creates and antitrust exemption for certain pharmacies. Rules, regulations and guidance specific to prescription drug pricing, generic utilization and specialty pharmacy. Issues impacting PBMs included in the Prescription Drug User Fee Act reauthorization and the Generic Drug User Fee Reauthorization | Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2012-04-11T16:29:49.920000-04:00 | |
| 1225329 | AMERICAN HEART ASSOCIATION 134face3-6ebe-45c9-bfa0-8caf36f27178 | Q1 | AMERICAN HEART ASSOCIATION | 2525 | AMERICAN HEART ASSOCIATION | 2012 | first_quarter | PHA | The Role of Cardiovascular Assessment in the Preapproval and Postapproval Settings for Drugs and Biologics Developed for the Treatment of Obesity (FDA-2012-N-0001) | Agency for Healthcare Research & Quality (AHRQ),Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Education, Dept of,Environmental Protection Agency (EPA),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),Natl Institutes of Health (NIH),Office of Management & Budget (OMB),SENATE,Treasury, Dept of | 175818 | 0 | 0 | 2012-04-12T08:58:04.580000-04:00 | |
| 1225537 | PARRY, ROMANI, DECONCINI & SYMMS 3f87d9d3-5e14-4f65-96c2-97902bf50b9c | Q1 | PARRY, ROMANI, DECONCINI & SYMMS | 30792 | POZEN, INC. | 2012 | first_quarter | PHA | To provide incentives for new drug development. No specific bills pending. | HOUSE OF REPRESENTATIVES,SENATE | 36000 | 0 | 0 | 2012-04-12T12:04:20.937000-04:00 | |
| 1225784 | DUTKO WORLDWIDE, LLC 2a9afa7b-71a9-4de0-b283-0f11aaa50b7f | Q1 | DUTKO WORLDWIDE, LLC | 12868 | NEWAYS INTERNATIONAL | 2012 | first_quarter | PHA | Monitor legislation pertaining to dietary supplements and pharmaceuticals, particularly the Food Safety Modernization Act (PL 111-353) and Patient Protection and Affordable Care Act (PL 111-148). | Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2012-04-12T15:15:41.083000-04:00 | |
| 1225855 | CAPITOL HILL CONSULTING GROUP 7d554e61-3689-4511-82df-e90df26a7a08 | Q1 | CAPITOL HILL CONSULTING GROUP | 72053 | PURDUE PHARMA LLP | 2012 | first_quarter | PHA | Controlled Drug Substances Act (21 USC 13) Stop Oxy Abuse Act (H.R. 1316) | HOUSE OF REPRESENTATIVES,SENATE | 32000 | 0 | 0 | 2012-04-12T15:39:04.043000-04:00 | |
| 1226036 | BLUECROSS BLUESHIELD OF TENNESSEE 60b859f6-5f41-46cf-9e67-75c9148df8b1 | Q1 | BLUECROSS BLUESHIELD OF TENNESSEE | 6440 | BLUECROSS BLUESHIELD OF TENNESSEE | 2012 | first_quarter | PHA | General Pharmacy Issues | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2012-04-13T09:50:08.230000-04:00 | |
| 1226069 | DENNY MILLER ASSOCIATES e3b9698f-b159-4923-bdeb-9e5aa7d1fb0c | Q1 | DENNY MILLER ASSOCIATES | 25328 | CELL THERAPEUTICS | 2012 | first_quarter | PHA | Prescription Drug User Fee Act Reauthorization (no number), provisions relating to approval of new drugs. H.R. 4132 - Faster Access to Specialized Treatments Act, all sections; S. 2113 Transforming the Regulator Environment to Accelerate Access to Treatments, all sections. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2012-04-13T10:03:25.597000-04:00 | |
| 1226783 | EVERTZ GROUP LLC e3aa2c0a-3931-459e-8d30-8ada4735818b | Q1 | EVERTZ GROUP LLC | 400497446 | MYLAN INC. | 2012 | first_quarter | PHA | Involvement of the generic pharmaceutical industry in the President's Emergency Plan for AIDS Relief (PEPFAR). Supply Chain Management System of the PEPFAR program. | Office of Natl AIDS Policy,SENATE,State, Dept of (DOS),U.S. Agency for International Development (USAID) | 30000 | 0 | 0 | 2012-04-13T15:50:39.170000-04:00 | |
| 1226822 | ACADEMY OF MANAGED CARE PHARMACY 5fd35b50-d60f-48f6-ab39-af48131b6a67 | Q1 | ACADEMY OF MANAGED CARE PHARMACY | 48793 | ACADEMY OF MANAGED CARE PHARMACY | 2012 | first_quarter | PHA | S 27 - legislation that would authorize the Federal Trade Commission to presume illegal agreements between manufacturers of innovator and generic pharmaceutical products in which the generic manufaturer agrees to delay entry into the market in exhange for compensation from the manufacturer of the innovator product HR 1483 & HR 3988 - would introduce reforms and reauthorizations of the FDA, including the prescription drug user fee act S 296 and HR 2245 - legislation that would address shortages of prescription drugs HR 2746 - legislation that would require cost-sharing parity between all cancer medications within pharmacy benefits regulated under ERISA HR 979 - legislation that would implement transparency standards and other regulations for pharmacy benefit managers working within the Federal Employees Health Benefits Program HR 4209 - legislation that would require group and individual health insurance policies covered under ERISA and which use a formulary for prescription drug coverage to charge the same co-payment/co-insurance rate for specialty drugs as the co-payment/co-insurance rate for non-preferred brand drugs HR 1971 and S 1058 - legislation that would impose transparency and audit requirements for PBMs contracting with group health plans. | HOUSE OF REPRESENTATIVES,SENATE | 190000 | 0 | 0 | 2012-04-13T16:13:03.630000-04:00 | |
| 1226954 | RED+BLUE STRATEGIES 9849f021-57cd-40b7-9592-7c8230d0d52d | Q1 | RED+BLUE STRATEGIES | 400693064 | PEW CHARITABLE TRUSTS | 2012 | first_quarter | PHA | H.R. 2182/S. 1734 - Generating Antibiotic Incentives Now Act . Supporting work to increase innovation and development of new antibiotics. S. 1584 - Drug Safety and Accountability Act- Supporting legislation and related Congressional activity regarding upstream supply stream safety. H.R. 3026- Safeguarding America's Pharmaceuticals Act. Supporting legislation and congressional activity regarding downstream supply chain safety. Policies related to the growing concerns regarding drug shortage issues in hospitals across the country. Related issues being considered in pending User Fee Reauthorization legislation. | Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2012-04-13T17:25:17.583000-04:00 | |
| 1227328 | THE OB-C GROUP, LLC 9994448a-354c-4b0e-bf28-178e32c09f7a | Q1 | THE OB-C GROUP, LLC | 29802 | ELI LILLY | 2012 | first_quarter | PHA | No specific bill number: matters relating to pharmaceutical manufacturers and Medicare Part D. | HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2012-04-16T10:06:35.680000-04:00 | |
| 1227341 | HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) e0a50bc2-8b90-43fc-83d9-ef0ee01d588f | Q1 | HEALTHCARE DISTRIBUTION ALLIANCE(HDA)(FORMERLY HEALTHCARE DISTRIBUTION MANAGEMENT ASSOCIATION (HDMA) | 28776 | HEALTHCARE DISTRIBUTION ALLIANCE (FORMERLY - HDMA) | 2012 | first_quarter | PHA | Importation of Presceiption Drugs (S. 319, H.R. 147); Rx Pedigree (H.R. 3026/draft PDUFA legislation); NASPER Reauthorization (H.R. 866); Prescription Drug Monitoring Programs (S. 2254/H.R. 4292); Pill Mill Crackdown Act (H.R. 1065/S. 1760); Drug Abuse (S. 507); Drug Shortages (S. 296/H.R. 2245/H.R. 3839/draft PDUFA legislation); Cargo/Product Theft (S. 1002/H.R. 4223); Import Safety (S. 1584); Counterfeit Drugs (S. 1886/H.R. 3668); Internet Pharmacy (S. 2002/H.R. 4095) | Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 282000 | 0 | 0 | 2012-04-16T10:11:43.433000-04:00 | |
| 1227405 | FORGE FEDERAL AFFAIRS LLC d59d6016-24e1-40f2-b475-ec90c7fa7d9d | Q1 | FORGE FEDERAL AFFAIRS LLC | 400865535 | LILLY USA LLC | 2012 | first_quarter | PHA | Issues related to Prescription Drug User Fee Act (PDUFA). | 0 | 0 | 2012-04-16T10:36:19.317000-04:00 | |||
| 1227536 | NATIONAL ASSOCIATION OF CHAIN DRUG STORES 807c9acc-a16b-4694-a66d-0aa5aa56a9d9 | Q1 | NATIONAL ASSOCIATION OF CHAIN DRUG STORES | 26672 | NATIONAL ASSOCIATION OF CHAIN DRUG STORES | 2012 | first_quarter | PHA | S.27, Preserve Access to Affordable Generics Act S.31, Prescription Drug and Health Improvement Act of 2011 S.319, Pharmaceutical Market Access and Drug Safety Act of 2011 H.R.147, Prescription Drug Affordability Act H.R.741, To amend the Federal Food, Drug, and Cosmetic Act to prohibit the marketing of authorized generic drugs H.R.979, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act H.R.1971, Pharmacy Competition and Consumer Choice Act of 2011 H.R.2128, STEAM (Stripping The E-Prescribe Arbitrary Mandates) Act of 2011 S.1058, Pharmacy Competition and Consumer Act of 2011 S.1356, Affordable Medicines Utilization Act of 2011 S.1584, Drug Safety and Accountability Act of 2011 H.R.3026, Safeguarding America's Pharmaceuticals Act of 2011 S.2002, To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of Internet Pharmacies | Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Drug Enforcement Administration (DEA),Federal Reserve System,Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Justice, Dept of (DOJ),SENATE | 560000 | 0 | 0 | 2012-04-16T11:08:27.217000-04:00 | |
| 1227647 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 5d875db2-0dbc-4fd8-8fdc-a515379e54cf | Q1 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | NATIONAL ASSOCIATION OF EPILEPSY CENTERS | 2012 | first_quarter | PHA | Issues related to anti-epileptic drugs. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 0 | 0 | 2012-04-16T11:42:16.477000-04:00 | ||
| 1227697 | AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS ea38054c-44e7-4af1-bb02-1798b25685b5 | Q1 | AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS | 1672 | AMERICAN ASSOCIATION OF ORAL AND MAXILLOFACIAL SURGEONS | 2012 | first_quarter | PHA | the Prescription Drug Abuse Prevention and Treatment Act of 2011 (S. 507/H.R. 1925) the Stop Oxy Abuse Act of 2011 (H.R. 1316) the Ryan Creedon Act of 2011 (H.R. 2119) Prescription Drug User Fee Act (PDUFA) reauthorization legislation | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Office of Natl Drug Control Policy (NDCP),SENATE | 27325 | 0 | 0 | 2012-04-16T12:05:42.737000-04:00 | |
| 1227800 | THORN RUN PARTNERS 2cfbbfeb-5d76-44c5-8711-ed272948ca44 | Q1 | THORN RUN PARTNERS | 400534596 | LONG TERM CARE PHARMACY ALLIANCE | 2012 | first_quarter | PHA | S.1560, Nursing Home Resident Pain Relief Act of 2011; Issues related to the implementation of the Affordable Care Act (ACA, DEA enforcement of controlled substances in nursing homes and the practice of consultant pharmacy. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2012-04-16T12:44:31.640000-04:00 | |
| 1227907 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. c9cc548e-2c69-4add-a243-572b710386e6 | 1A | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | NATIONAL ASSOCIATION OF EPILEPSY CENTERS | 2012 | first_quarter | PHA | Issues related to anti-epileptic drugs. | Agency for Healthcare Research & Quality (AHRQ),Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 0 | 0 | 2012-04-16T13:14:23.227000-04:00 | ||
| 1228054 | POLICY DIRECTIONS INC. d15fcfc3-43cc-46c1-8a50-617eaa83fe5b | Q1 | POLICY DIRECTIONS INC. | 31747 | ALPHARMA INC/PFIZER ANIMAL HEALTH (FORMERLY KNOWN AS ALPHARMA INC ) | 2012 | first_quarter | PHA | Antibiotics in animal foods Drug approvals Drugs in animal foods Implementation of: All titles, to end the use of certain antibiotics in animal feed if those antibiotics are used in human medicine. HR 965 and S. 1211 and efforts to require the manufacturers of antibiotics used in animal feed to make certain reports to FDA. Legislation to reform FDA regulation of federal imported and domestic food safety with emphasis on those titles related to the import of ingredients for food and drugs, as well as country-of-origin labeling. Monitor legislative and regulatory developments related to the Animal Drug User Fee Act reauthorization, with related developments of the Generic Animal Drug UserFee Act. Monitor developments of the Food & Drug Administrations development of its Advanced Feed Safety System related to the use of animal drugs in livestock and poultry feeds. | Agriculture, Dept of (USDA),Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2012-04-16T14:10:24.797000-04:00 | |
| 1228142 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 9a7a8e56-ebd8-4684-a4aa-bd7cbb3f232b | Q1 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | THE HEMOPHILIA ALLIANCE | 2012 | first_quarter | PHA | Issues realted to the 340B drug discount program. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2012-04-16T14:42:57.043000-04:00 | |
| 1228154 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 7f9f0a66-6fe6-45f8-8e55-03b3ea30421c | Q1 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | NATIONAL HEMOPHILIA FOUNDATION | 2012 | first_quarter | PHA | Issues related to hemophilia treatments, specialty pharmacies and the 340B drug purchasing program. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 50000 | 0 | 0 | 2012-04-16T14:48:02.390000-04:00 | |
| 1228251 | MCKENNA, LONG & ALDRIDGE 8bc1055f-a5e0-4993-b03d-2c6e42f429a3 | Q1 | MCKENNA, LONG & ALDRIDGE | 76913 | REVANCE THERAPEUTICS, INC. | 2012 | first_quarter | PHA | Any issues impacting biopharmaceutical companies | 0 | 0 | 2012-04-16T15:21:42.243000-04:00 | |||
| 1228296 | NOVO NORDISK INC. e5e79b3e-bfbf-4aa3-87c3-6e8278709e72 | Q1 | NOVO NORDISK INC. | 284790 | NOVO NORDISK INC. | 2012 | first_quarter | PHA | P.L. 111-148, Patient Protection and Affordable Care Act of 2009 (ACA) and P.L. 111-152, The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample reporting provisions; HR 2112 FY12 Agriculture, Commerce/State/Justice, Transportation, & HUD Appropriations on prescription drug reimportation; Prescription Drug User Fee Act reauthorization Best Pharmaceuticals for Children Act/Pediatric Research Exclusivity Act; Supply Chain safety; Pharmaceutical Traceability Enhancement Code (Rx TEC) Act | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Natl Institutes of Health (NIH),SENATE,White House Office | 670000 | 0 | 0 | 2012-04-16T15:37:04.017000-04:00 | |
| 1228319 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. 10b6347b-c0d0-42a1-96a5-1656f01c1fc9 | Q1 | CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | 8511 | AMERICAN SOCIETY OF HEMATOLOGY | 2012 | first_quarter | PHA | Issues related to drug shortages. S.296/HR2245 Preserving Access to Life Saving Medications Act, HR3839 Drug Shortage Prevention Act | Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2012-04-16T15:44:13.423000-04:00 | |
| 1229465 | THE INGRAM GROUP LLC 590253d5-05e1-4668-99a9-5ec0de1244fe | Q1 | THE INGRAM GROUP LLC | 400577737 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) | 2012 | first_quarter | PHA | Issues related to pharmaceutical importation. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2012-04-17T13:30:00.397000-04:00 | |
| 1229859 | STEVE BUYER GROUP b2d28ab3-5c5f-4fdc-bf11-f736544d250e | Q1 | STEVE BUYER GROUP | 400701097 | OMNICARE | 2012 | first_quarter | PHA | Advocacy in support of S 1560 promoting changes to the Controlled Substance Act providing access to pain medication for nursing. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2012-04-17T15:46:40.827000-04:00 | |
| 1229871 | NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC 1e80caf3-aa4c-4ddd-8e63-501588381f21 | Q1 | NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC | 400689052 | TEVA PHARMACUETICALS USA | 2012 | first_quarter | PHA | Issues affecting user fee act | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2012-04-17T15:48:46.983000-04:00 | |
| 1229983 | NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC bc24bacd-7041-4843-96a1-f2d34c0d437c | Q1 | NORTH SOUTH GOVERNMENT STRATEGIES, FKA JDM PUBLIC STRATEGIES, LLC | 400689052 | WOCKHARDT USA LLC | 2012 | first_quarter | PHA | Preemption issues under the FDA Act; user fee issues | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2012-04-17T16:12:33.850000-04:00 | |
| 1230213 | GREATER NEW YORK HOSPITAL ASSOCIATION 2c7aae11-6038-4111-a769-016093703757 | Q1 | GREATER NEW YORK HOSPITAL ASSOCIATION | 16830 | GREATER NEW YORK HOSPITAL ASSOCIATION | 2012 | first_quarter | PHA | Reducing the costs of pharmaceuticals, medical devices, and supplies for consumers and health care providers, including drug shortage legislation (S. 296, H.R. 2245), potential drug shortage legislation, potential price gouging legislation, medical device pricing issues, and preserving access to group purchasing organizations. | Centers For Medicare and Medicaid Services (CMS),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE,White House Office | 220000 | 0 | 0 | 2012-04-17T17:06:13.713000-04:00 | |
| 1230787 | SQUIRE PATTON BOGGS 42c605eb-61ad-4af5-adfe-dd2e94f1862d | Q1 | SQUIRE PATTON BOGGS | 30906 | KV PHARMACEUTICAL COMPANY | 2012 | first_quarter | PHA | Issues regarding Medicaid coverage of Makena and regulatory treatment of Makena. | HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2012-04-18T06:46:55.877000-04:00 | |
| 1230835 | SQUIRE PATTON BOGGS 68a033f1-5b98-445a-8cf2-6b162d4520ef | Q1 | SQUIRE PATTON BOGGS | 30906 | RANBAXY INC. | 2012 | first_quarter | PHA | S. 27, Preserve Access to Affordable Generics; H.R. 1483, Drug Safety Enhancement Act; Implementation of P.L. 111-148, Patient Protection & Affordable Care Act; H.R. 3630, the Middle Class Tax Relief and Job Creation Act; Prescription Drug User Fee Reauthorization issues. | HOUSE OF REPRESENTATIVES,SENATE | 180000 | 0 | 0 | 2012-04-18T07:11:21.493000-04:00 | |
| 1230920 | EISAI INC. 84b13d4a-8786-4369-99f8-e8f3a328ee50 | Q1 | EISAI INC. | 400321512 | EISAI INC. | 2012 | first_quarter | PHA | drug shortages, supply chain integrity DEA-FDA issues Prescription Drug User Fee Act reauthorization | HOUSE OF REPRESENTATIVES,SENATE,Treasury, Dept of | 930000 | 0 | 0 | 2012-04-18T08:28:52.830000-04:00 | |
| 1230933 | CASSIDY & ASSOCIATES, INC. c02d2e74-8f2a-43f6-aa45-8285a07f8a90 | Q1 | CASSIDY & ASSOCIATES, INC. | 8453 | ADAMIS PHARMACEUTICALS CORPORATION | 2012 | first_quarter | PHA | regualtory relief with FDA | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2012-04-18T08:44:57.390000-04:00 | |
| 1231257 | ARTEMIS STRATEGIES 3a7558d2-d92f-4f15-b243-3c9fc9243185 | 1T | ARTEMIS STRATEGIES | 82990 | SCRIPS AMERICA | 2012 | first_quarter | PHA | FDA approval of DESI drugs | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 1 | 2012-04-18T10:34:07-04:00 | |
| 1231329 | UPS (UNITED PARCEL SERVICE) 9b5edd61-2c14-4aac-bfe0-3046572e20a3 | Q1 | UPS (UNITED PARCEL SERVICE) | 39223 | UPS (UNITED PARCEL SERVICE) | 2012 | first_quarter | PHA | - S.1584/HR 3026 "Safeguarding Americas Pharmaceuticals Act of 2011"; all issues relating to 3rd party logistics - Supply Chain Safety (Serialization v. Pedigree) | Commerce, Dept of (DOC),Defense, Dept of (DOD),Energy, Dept of,Federal Aviation Administration (FAA),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Internal Revenue Service (IRS),Labor, Dept of (DOL),Pension Benefit Guaranty Corporation (PBGC),Postal Regulatory Commission,SENATE,State, Dept of (DOS),Transportation, Dept of (DOT),Transportation Security Administration (TSA),Treasury, Dept of,U.S. Customs & Border Protection,U.S. Trade Representative (USTR),White House Office | 1476280 | 0 | 0 | 2012-04-18T10:52:39.653000-04:00 | |
| 1231384 | NATIONAL RURAL HEALTH ASSOCATION 964a5b20-f679-4ebf-a210-5efee6199e1e | Q1 | NATIONAL RURAL HEALTH ASSOCATION | 53048 | NATIONAL RURAL HEALTH ASSOCATION | 2012 | first_quarter | PHA | Support for 340B drug program. | Centers For Medicare and Medicaid Services (CMS),Federal Communications Commission (FCC),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 171771 | 0 | 0 | 2012-04-18T11:05:01.800000-04:00 | |
| 1231400 | ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM 6a288383-cd6a-4b8d-8940-6cb87bf8b109 | Q1 | ATRIUM HEALTH-FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM | 58534 | ATRIUM HEALTH - FORMERLY KNOWN AS CAROLINAS HEALTHCARE SYSTEM | 2012 | first_quarter | PHA | HR 2245, S 296 Supportive of language increasing access to life saving medications. | HOUSE OF REPRESENTATIVES,SENATE | 10734 | 0 | 0 | 2012-04-18T11:07:07.473000-04:00 | |
| 1231508 | PD FRAZER CONSULTING, INC. 31064a87-ace7-41e2-8a66-c47d35e7d3e6 | Q1 | PD FRAZER CONSULTING, INC. | 65998 | CANADA INTERNATIONAL PHARMACY ASSOCIATION | 2012 | first_quarter | PHA | Monitor the development of proposed bills about the importation of prescription drugs. | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2012-04-18T11:22:54.713000-04:00 | |
| 1231679 | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) 668ea93f-0b6b-420d-881b-cf81a1b531ea | Q1 | MCGUIREWOODS CONSULTING (A SUBSIDIARY OF MCGUIREWOODS LLP) | 24486 | ALLIED MEDICAL SUPPLY, INC. | 2012 | first_quarter | PHA | Issues affecting resellers of pharmaceutical products | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2012-04-18T11:46:09.113000-04:00 | ||
| 1231884 | FAEGRE BAKER DANIELS CONSULTING fc2537db-2824-450c-ad5a-d10901b8a0c9 | Q1 | FAEGRE BAKER DANIELS CONSULTING | 34158 | ALLIANCE FOR SAFE ONLINE PHARMACIES (ASOP) | 2012 | first_quarter | PHA | On-line Pharmacies | Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2012-04-18T12:11:41.310000-04:00 | |
| 1232028 | MARSHFIELD CLINIC HEALTH SYSTEM bd24e3ca-f214-478c-98cb-08fad39c688f | Q1 | MARSHFIELD CLINIC HEALTH SYSTEM | 57830 | MARSHFIELD CLINIC HEALTH SYSTEM | 2012 | first_quarter | PHA | Leukemia drug shortages are reaching crises dimensions, especially the recent shortage of cytarabine. In the United States, about 10,000 individuals are diagnosed with AML every year. Cytarabine is the backbone of AML therapy and is the basis for its cure. Without this drug patient outcomes are limited. We raised the concerns of shortages experienced by the Clinic to Senate and FDA | Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Medicare Payment Advisory Commission (MedPAC),SENATE | 130000 | 0 | 0 | 2012-04-18T12:40:39.350000-04:00 | |
| 1232202 | INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) 67d3be70-4d0d-4f62-b330-914bd4b92713 | Q1 | INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) | 400337570 | INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS (IACP) | 2012 | first_quarter | PHA | Online Pharmacy Act and other issues impacting pharmacies and the legitimate practice of pharmacy | Centers For Medicare and Medicaid Services (CMS),Drug Enforcement Administration (DEA),Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 25073 | 0 | 0 | 2012-04-18T13:18:51.787000-04:00 | |
| 1232496 | WHITMER & WORRALL, LLC 670fe07e-7e49-474f-8020-c550f9689f14 | Q1 | WHITMER & WORRALL, LLC | 292892 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA (PHRMA) | 2012 | first_quarter | PHA | Issues related to monitoring healthcare reform. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2012-04-18T14:03:06.317000-04:00 | |
| 1233123 | WINSTON & STRAWN LLP aeac9b23-00f5-4b7c-a3f7-88dedfa5995e | Q1 | WINSTON & STRAWN LLP | 41682 | FRESENIUS KABI USA (FORMERLY KNOWN AS APP PHARMACEUTICALS INC ) | 2012 | first_quarter | PHA | Represent the client on issues related to assuring a safe, reliable supply of heparin and also on patent matters, including settlements and extensions. Legislation of interest includes the America Invents Act of 2011 (H.R. 1249). | HOUSE OF REPRESENTATIVES,SENATE | 0 | 0 | 2012-04-18T15:13:43.487000-04:00 | ||
| 1233381 | AMERICAN ADVERTISING FEDERATION 04892c29-2f32-4cc0-ac9a-811a91769a63 | Q1 | AMERICAN ADVERTISING FEDERATION | 1411 | AMERICAN ADVERTISING FEDERATION | 2012 | first_quarter | PHA | Oppose proposals to limit or restrict direct-to-consumer advertising of pharmaceuticals Oppose proposals to require a moratorium on the advertising of new prescription medicines Oppose proposals to extend the Food and Drug Administration authority for the advertising of over-the-counter medications HR 741 To amend the Federal Food, Drug and Cosmetic Act to prohibit the marketing of authorized generic drugs - oppose H.Res. 343 Disapproving the Supreme Courts decision in Sorrell v. IMS Health - oppos Oppose proposals to add overly-burdensome product warnings to DTC advertising | Agriculture, Dept of (USDA),Centers For Disease Control & Prevention (CDC),Commerce, Dept of (DOC),Federal Communications Commission (FCC),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 20000 | 0 | 0 | 2012-04-18T15:43:29.493000-04:00 | |
| 1233730 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS 9abbb687-133a-49b6-8dce-7da99d9263d5 | Q1 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | 3457 | AMERICAN SOCIETY OF HEALTH-SYSTEM PHARMACISTS | 2012 | first_quarter | PHA | H.R. 2245, S. 296, "Preserving Access to Life-Saving Medications Act," all provisions and H.R. 3839, "Drug Shortage Prevention Act of 2012." Support for S.1584, "The Drug Safety and Accountability Act," a bill to ensure drug supply safety and give FDA mandatory recall authoirty. Contact concerning Food and Drug Administartion (FDA) authority to manage drug shortages. Communications to FDA on expansion of over the counter medicines (OTC), barcoding, and off label promotion of prescription drugs. Presentations to the FDA on OTC Expansion and Anthrax Medikits. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 250000 | 0 | 0 | 2012-04-18T16:44:12.250000-04:00 | |
| 1233791 | POWERS PYLES SUTTER & VERVILLE, P.C. 6661c533-d4bd-47e2-8657-59ad713dc640 | Q1 | POWERS PYLES SUTTER & VERVILLE, P.C. | 32008 | 340B HEALTH | 2012 | first_quarter | PHA | Section 340B of the Public Health Service Act, Section 1927 of the Social Security Act and issues related to (1) administration of the 340B Drug Discount Program, (2) implementation of 340B-related provisions in the Patient Protection and Affordable Care Act of 2010, (3) funding of the Health Resources and Services Administration (HRSA) under the FY2012 Labor Health & Human Services & Education appropriations bills, and (4) enactment of the 340B Program Improvement Act of 2011 (H.R. 2674). | Centers For Medicare and Medicaid Services (CMS),Federal Trade Commission (FTC),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,SENATE | 45000 | 0 | 0 | 2012-04-18T16:59:54.833000-04:00 | |
| 1233862 | BROWN RUDNICK LLP f08f6b71-fe6e-4ddd-847d-dd5c898c7b4c | Q1 | BROWN RUDNICK LLP | 287895 | HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC | 2012 | first_quarter | PHA | Issues related to supply chain safety; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; H.R. 147 & S. 319 Pharmaceutical Market Access and Drug Safety Act; H.R. 866 - National All Schedules Prescription Reporting Reauthorization Act of 2011; H.R. 1065 & S. 1760- Pill Mill Crackdown Act of 2011; H.R 2245, H.R. 3839 S. 296 Related to Drug Shortages S. 507 - Prescription Drug Abuse , Prevention and Treatment Act of 2011 H.R. 2245 & S. 296 - Preserving Access to Life-Saving Medication Act of 2011 H.R. 4233 & S. 1002 - Safe Doses Act S. 1584 - Drug Safety and Accountability Act of 2011 S. 1886 & H.R. 3668 - Counterfeit Drug Penalty Enhancement Act of 2011 S. 2002 & H.R. 4095 - Online Pharmacy Safety Act | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2012-04-18T17:20:33.983000-04:00 | |
| 1233872 | BROWN RUDNICK LLP e58d263b-2bf5-42b4-99f4-3e0349261f10 | 1A | BROWN RUDNICK LLP | 287895 | HEALTHCARE DISTRIBUTION ALLIANCE F/K/A HEALTHCARE DISTRIBUTION MANAGEMENT ASSOC | 2012 | first_quarter | PHA | Issues related to supply chain safety; H.R. 3026 Safeguarding America's Pharmaceuticals Act of 2011; H.R. 147 & S. 319 Pharmaceutical Market Access and Drug Safety Act; H.R. 866 - National All Schedules Prescription Reporting Reauthorization Act of 2011; H.R. 1065 & S. 1760- Pill Mill Crackdown Act of 2011; H.R 2245, H.R. 3839 S. 296 Related to Drug Shortages S. 507 - Prescription Drug Abuse , Prevention and Treatment Act of 2011 H.R. 2245 & S. 296 - Preserving Access to Life-Saving Medication Act of 2011 H.R. 4233 & S. 1002 - Safe Doses Act S. 1584 - Drug Safety and Accountability Act of 2011 S. 1886 & H.R. 3668 - Counterfeit Drug Penalty Enhancement Act of 2011 S. 2002 & H.R. 4095 - Online Pharmacy Safety Act | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2012-04-18T17:21:36.527000-04:00 | |
| 1233937 | GENENTECH, INC 185f03dc-bfca-499f-9554-258a9a6dce5c | Q1 | GENENTECH, INC | 15920 | GENENTECH INC | 2012 | first_quarter | PHA | Monitor Drug Safety and legislation; Advocacy related to ensuring access to necessary medicines | HOUSE OF REPRESENTATIVES,SENATE | 1137780 | 0 | 0 | 2012-04-18T17:39:10.797000-04:00 | |
| 1234164 | RICCHETTI INCORPORATED 3a67d34c-b8d6-4fd4-aab4-29919f67c97c | Q1 | RICCHETTI INCORPORATED | 62778 | ELI LILLY AND COMPANY | 2012 | first_quarter | PHA | Issues related to pediatric exclusivity policy | HOUSE OF REPRESENTATIVES,SENATE | 15000 | 0 | 0 | 2012-04-18T19:45:30.753000-04:00 | |
| 1234283 | HEARTLAND SOLUTIONS GROUP, INC. a1e68986-5164-4b29-b518-66d40d270b97 | Q1 | HEARTLAND SOLUTIONS GROUP, INC. | 312133 | ZEBRA TECHNOLOGIES CORPORATION | 2012 | first_quarter | PHA | Any and all issues related to barcode, secure identification and real-time location systems. | HOUSE OF REPRESENTATIVES,SENATE | 41250 | 0 | 0 | 2012-04-18T22:18:18.103000-04:00 | |
| 1234506 | FLYNN & ASSOCIATES, INC. 350db48e-2ca4-4b2f-83c6-fa82a147d0cd | Q1 | FLYNN & ASSOCIATES, INC. | 15020 | PHARMACEUTICAL INDUSTRY LABOR-MANAGEMENT ASSOCIATION | 2012 | first_quarter | PHA | FDA Reauthorization Pharmaceutical Industry Employment Issue | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2012-04-19T07:33:45.623000-04:00 | |
| 1235163 | AMERICAN VETERINARY MEDICAL ASSOCIATION de6d95ae-4a2a-46cc-9276-87c0352213f5 | Q1 | AMERICAN VETERINARY MEDICAL ASSOCIATION | 3630 | AMERICAN VETERINARY MEDICAL ASSOCIATION | 2012 | first_quarter | PHA | H.R. 965/S. 1211, Preservation of Antibiotics for Medical Treatment Act H.R. 1406, Fairness to Pet Owners Act ADUFA and AGDUFA Reauthorization | Agriculture, Dept of (USDA),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,SENATE | 170000 | 0 | 0 | 2012-04-19T10:18:09.467000-04:00 | |
| 1235652 | MCDERMOTT WILL & SCHULTE LLP 698dbff6-ae9f-41e2-a5c2-8e57e34c946e | Q1 | MCDERMOTT WILL & SCHULTE LLP | 24338 | ALLERGAN, INC. | 2012 | first_quarter | PHA | Issues related to Section 340B of the Public Health Service Act; FDA issues; health reform implementation | Executive Office of the President (EOP),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2012-04-19T11:05:44.267000-04:00 | |
| 1235881 | THE DUBERSTEIN GROUP INC. 487e89f2-9199-44ed-a22a-54e1a27b1eff | Q1 | THE DUBERSTEIN GROUP INC. | 12675 | PFIZER INC. | 2012 | first_quarter | PHA | Addressing drug shortages, including enhanced evaluation of companies and manufacturing sites, real-cause analysis, inventory at companies, improving quality control processes - Proposed legislation re these issues. Opiate abuse issues - Proposed legislation re this issue. Tracking and tracing medicines - Proposed legislation re this issue. Antidote for exposure to chemical agents - Executive Branch action re this issue. | HOUSE OF REPRESENTATIVES,SENATE | 100000 | 0 | 0 | 2012-04-19T11:25:22.897000-04:00 | |
| 1236075 | STRATEGIES 360 ef16d67a-6c4d-4f48-ac9e-1fc519db75b8 | Q1 | STRATEGIES 360 | 79175 | MEDCO HEALTH SOLUTIONS INC AND ITS SUBSIDIARIES | 2012 | first_quarter | PHA | Drug Utilization Review Program, Competitive bidding, HR 5597: Medicare Patient IVIG Access Demonstration Project, Medical Loss Ratio, Performance-Based Pharmacy Reimbursement, PDUFA & Biosimilars, | Commerce, Dept of (DOC),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2012-04-19T11:42:39.413000-04:00 | |
| 1236654 | CAPITOLOGIC LLC d252a314-ff5a-45e7-aca1-e5610e5e21ab | Q1 | CAPITOLOGIC LLC | 400426045 | BULALAW, LLC | 2012 | first_quarter | PHA | Federal funding of illegal prescription drug market interventions | Drug Enforcement Administration (DEA),HOUSE OF REPRESENTATIVES,Justice, Dept of (DOJ),Natl Institute of Justice,Office of Justice Program,SENATE | 10000 | 0 | 0 | 2012-04-19T12:41:43.837000-04:00 | |
| 1237032 | RUBICON ADVISORS, LLC 4264d058-d8ae-49e7-bc7f-962b9724aeb4 | Q1 | RUBICON ADVISORS, LLC | 315091 | WATSON PHARMACEUTICALS INC | 2012 | first_quarter | PHA | Patent Reform H.R. 1908, Import Safety Act H.R. 2100 Affordable Health Choices Act Patent Settlements H.R. 1432 S 316 Generic Biologics S 1685 H.R. 5629 Physician Payment Sunshine Act S 2029 | HOUSE OF REPRESENTATIVES,SENATE | 98000 | 0 | 0 | 2012-04-19T13:19:15.850000-04:00 | |
| 1237060 | RUBICON ADVISORS, LLC 19d7edb7-89a8-48f1-867a-b84f73d3abda | Q1 | RUBICON ADVISORS, LLC | 315091 | TEVA PHARMACEUTICALS USA | 2012 | first_quarter | PHA | Patent Settlements H.R. 1432, Generic Biologies S H.R. 1695, H.R. 5629, Physican Payment Sunshine Act S 2029, Patent Reform H.R. 1908, Import Safety Act H.R. 3100 Affodable Health Choices Act | HOUSE OF REPRESENTATIVES,SENATE | 105000 | 0 | 0 | 2012-04-19T13:21:28.227000-04:00 | |
| 1237075 | RUBICON ADVISORS, LLC dc7233b6-825d-4647-a996-c3b04994b223 | Q1 | RUBICON ADVISORS, LLC | 315091 | GILEAD SCIENCES | 2012 | first_quarter | PHA | H.R. 822, H.R. 1943, H.R. 6114, S-2969 | HOUSE OF REPRESENTATIVES,SENATE | 75000 | 0 | 0 | 2012-04-19T13:24:36.307000-04:00 | |
| 1237279 | MCDERMOTT WILL & SCHULTE LLP 9ad3d6b9-19f5-4375-ade9-f599daf88595 | Q1 | MCDERMOTT WILL & SCHULTE LLP | 24338 | RURAL REFERRAL CENTER/SOLE COMMUNITY HOSPITAL COALITION | 2012 | first_quarter | PHA | Amendments to Section 340B of the Public Health Service Act to gain eligibility for rural referral centers and sole community hospitals in the federal discount drug purchasing program. | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 130000 | 0 | 0 | 2012-04-19T13:47:03.500000-04:00 | |
| 1237301 | RUBICON ADVISORS, LLC f74fab88-5d56-4a72-94d1-f5bab4789bcb | Q1 | RUBICON ADVISORS, LLC | 315091 | BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. | 2012 | first_quarter | PHA | Physician Payment Sunshine Act S 2029 Patent Settlements H.R. 14328 .316 Affordable Healthcare Choices Act | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2012-04-19T13:50:15.860000-04:00 | |
| 1237500 | CONSUMER HEALTHCARE PRODUCTS ASSOCIATION 6edc489f-0cc2-45d0-837d-1551d74674cb | Q1 | CONSUMER HEALTHCARE PRODUCTS ASSOCIATION | 29403 | CONSUMER HEALTHCARE PRODUCTS ASSOCIATION | 2012 | first_quarter | PHA | Pseudoephedrine Pseudoephedrine - potential legislation to implement real-time, stop-sale electronic tracking system for sales of medications containing pseudoephedrine in order to preserve consumer access to the ingredient, common in popular cold and allergy medications (no bill number) | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 210000 | 0 | 0 | 2012-04-19T14:10:39.883000-04:00 | |
| 1237782 | PODESTA GROUP, INC. 937fcabc-20d9-4259-86b2-f0eda94d4225 | Q1 | PODESTA GROUP, INC. | 31680 | EISAI INC. | 2012 | first_quarter | PHA | Drug issues; FDA-DEA issues. Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). H.R. 2112, Consolidated and Further Continuing Appropriations Act, 2012, Pub. L. 112-055. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2012-04-19T14:30:32.033000-04:00 | |
| 1237828 | APOTEX CORP. 336b2f2c-6d37-4b25-a45f-c3eec456e232 | Q1 | APOTEX CORP. | 310973 | APOTEX CORP. | 2012 | first_quarter | PHA | S. 1882, the FAIR Generics Act S. 27, the Preserve Access to Affordable Pharmaceuticals Act HR 3995, the Protecting Consumer Access to Generic Drugs Act S. 296, HR 2245, The Preserving Access to Life Savings Medications Act HR 4332, the Generic Drug Application Review Fairness Act HR 3998, Generic Drug and Biosimilar User Fee Act HR 2182, S. 1734, the Generating Antibiotic Incentives Now Act Amending Section 505(j) of the Food, Drug, and Cosmetic Act, concerning the ability of generic pharmaceutical manufacturers to file counterclaims seeking the correction of incorrect information submitted to FDA's Orange Book by patent owners or holders of New Drug Applications Supreme Court consideration of Novo Nordisk A/S and Novo Nordisk Inc. vs Caraco Pharmaceutical Laboratories Ltd. and Sun Pharmaceuticals Industries, Ltd. Prospective legislation establishing a generic drug user fee program Prospective legislation establishing a biosimilar user fee program Establishment of a federal track and trace system for pharmaceuticals The use of Risk Evaluation Mitigation Strategies (REMS) programs by brand drug companies to delay generic competition International Nonproprietary Names for Biosimilars | Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 200000 | 0 | 0 | 2012-04-19T14:32:52.267000-04:00 | |
| 1238268 | NOSSAMAN LLP 1eacfb18-0093-4782-8ed9-783a1a334e39 | Q1 | NOSSAMAN LLP | 29846 | AMERISOURCEBERGEN CORPORATION (FORMERLY "AMERISOURCEBERGEN SPECIALTY GROUP") | 2012 | first_quarter | PHA | H.R.905 and S.733, legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price. H.R. 1483, H.R.3026 and S.1584, pharmaceutical pedigree anti-counterfeiting legislation. H.R.2245 and S.296, legislation pertaining to drug manufacturing shortages. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2012-04-19T15:10:55.953000-04:00 | |
| 1238407 | ASSOCIATION OF NATIONAL ADVERTISERS, INC. 8be2179a-a457-4192-b39f-25489385d641 | Q1 | ASSOCIATION OF NATIONAL ADVERTISERS, INC. | 4653 | ASSOCIATION OF NATIONAL ADVERTISERS, INC. | 2012 | first_quarter | PHA | FDA proposals to change the requirements for the "major statement" in direct to consumer prescription drug advertisements Comments to FDA on proposal regarding disclosures for online prescription drug advertising FDA draft guidance for direct to consumer prescription drug ads on television | Commerce, Dept of (DOC),Federal Communications Commission (FCC),Federal Trade Commission (FTC),Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,Natl Telecommunications & Information Administration (NTIA),Office of Management & Budget (OMB),SENATE | 400000 | 0 | 0 | 2012-04-19T15:22:41.347000-04:00 | |
| 1238578 | NATIONAL COMMUNITY PHARMACISTS ASSOCIATION bae0563c-104a-4fe9-96c2-64a0658e4253 | Q1 | NATIONAL COMMUNITY PHARMACISTS ASSOCIATION | 27478 | NATIONAL COMMUNITY PHARMACISTS ASSOCIATION | 2012 | first_quarter | PHA | S. 1058 and H.R. 1971, the Pharmacy Competition and Consumer Choice Act of 2011; H.R. 1936, the Medicare Access to Diabetes Act of 2011; H.R. 1946, the Preserving Our Hometown Independent Pharmacies Act of 2011; S. 1560, Nursing Home Resident Pain Relief Act of 2011; S. 1699, a bill to reduce the costs of prescription drugs under the Medicare program; Sought Congressional support for the FTC investigation of the merger between two major national PBMs; SEE ADDENDUM S. 296, Preserving Access to Life-Savings Medications Act; Drug Cost Reduction Act; S. 2002 and H.R. 4095, Online Pharmacy Safety Act; S. 1251, Medicare and Medicaid FAST Act; S. 882, STOP Act; S. 319, Pharmaceutical Market Access and Drug Safety Act of 2011; S. 1002, SAFE Doses Act; H.R. 4215, The Medicare Pharmacy Transparency and Fair Auditing Act; Prescription Drug User Fee Act; Pharmaceutical Supply Chain Security; Drug Shortages legislation; Prescription drug diversion and abuse; TRICARE Pharmacy Benefit/Provisions for inclusion in National Defense Authorization Act for FY2013; Medicare Part B Revalidation | Agency for Healthcare Research & Quality (AHRQ),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Federal Trade Commission (FTC),Food & Drug Administration (FDA),Government Accountability Office (GAO),Health & Human Services, Dept of (HHS),Health Resources & Services Administration (HRSA),HOUSE OF REPRESENTATIVES,Office of Management & Budget (OMB),Office of Personnel Management (OPM),SENATE | 450000 | 0 | 0 | 2012-04-19T15:29:35.553000-04:00 | |
| 1239041 | PODESTA GROUP, INC. 3fe24a08-4808-4735-be46-01bcbc054770 | Q1 | PODESTA GROUP, INC. | 31680 | MILLENNIUM PHARMACEUTICALS INC | 2012 | first_quarter | PHA | Prescription Drug User Fee Act reauthorization. Product exclusivity issues; pedigree issues. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2012-04-19T16:00:14.237000-04:00 | |
| 1239517 | RYAN MACKINNON VASAPOLI AND BERZOK, LLP 1af7044b-fcfc-490c-bd42-6fe3de4f53e1 | Q1 | RYAN MACKINNON VASAPOLI AND BERZOK, LLP | 30187 | GENENTECH | 2012 | first_quarter | PHA | Monitor Drug Safety and pedigree legislation. | Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2012-04-19T16:36:27.703000-04:00 | |
| 1239588 | ARNOLD & PORTER KAYE SCHOLER LLP 2949561a-ea17-42cf-a2e2-c1efb7b40b8b | Q1 | ARNOLD & PORTER KAYE SCHOLER LLP | 4301 | INTERNATIONAL ACADEMY OF COMPOUNDING PHARMACISTS | 2012 | first_quarter | PHA | Issues related to the regulation of the practice of pharmacy compounding. | HOUSE OF REPRESENTATIVES,SENATE | 10000 | 0 | 0 | 2012-04-19T16:41:01.220000-04:00 | |
| 1239673 | RYAN MACKINNON VASAPOLI AND BERZOK, LLP fa0133cf-fb48-4aaf-b3dd-387fcbcf0f9d | Q1 | RYAN MACKINNON VASAPOLI AND BERZOK, LLP | 30187 | NOVO NORDISK | 2012 | first_quarter | PHA | P.L. 111-148- Patient Protection and Affordable Care Act of 2009 (ACA); P.L. 111-152- The Health Care & Education Affordability Reconciliation Act of 2010: Issues regarding comparative effectiveness, Prescription Drug User Fee Act reauthorization, prescription drug reimportation generally, implementation of Physician Payment Sunshine provisions and Prescription Drug Sample transparency reporting provisions. | Centers For Disease Control & Prevention (CDC),Centers For Medicare and Medicaid Services (CMS),Executive Office of the President (EOP),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Labor, Dept of (DOL),Natl Institutes of Health (NIH),SENATE | 30000 | 0 | 0 | 2012-04-19T16:46:32.237000-04:00 | |
| 1239704 | BUCHANAN INGERSOLL & ROONEY PC 4f2c336b-d5b8-4a13-b5c2-b81ba359ff6c | Q1 | BUCHANAN INGERSOLL & ROONEY PC | 55291 | GENERIC ANIMAL DRUG ALLIANCE | 2012 | first_quarter | PHA | Legislative issues relating to United States Food & Drug Administration. | Food & Drug Administration (FDA),HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2012-04-19T16:49:51.410000-04:00 | |
| 1240130 | TARPLIN, DOWNS & YOUNG, LLC 66cf120b-228a-4bfa-ba3f-89f5a2105b3d | Q1 | TARPLIN, DOWNS & YOUNG, LLC | 304736 | BIOTECHNOLOGY INDUSTRY ORGANIZATION | 2012 | first_quarter | PHA | **see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act S. 296 - Drug Shortage Act ***, no specific bill(s), Drug Safety, Prescription Drug Importation, Import Safety, biosimlars, PDUFA and associated policies | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 80000 | 0 | 0 | 2012-04-19T17:25:44.953000-04:00 | |
| 1240165 | TARPLIN, DOWNS & YOUNG, LLC 64e3e97b-b54d-4846-ac1f-9a64e6d1d173 | Q1 | TARPLIN, DOWNS & YOUNG, LLC | 304736 | PHRMA | 2012 | first_quarter | PHA | **see addendum page Prescription drug importation S. 319 Pharmaceutical Market Access and Drug Safety Act of 2011 H.R. 147 - Prescription Drug Affordability Act ***, no specific bill(s), prescription drug importation, import safety, Prescription Drug User Fee Act and associated policies | Centers For Medicare and Medicaid Services (CMS),HOUSE OF REPRESENTATIVES,SENATE | 70000 | 0 | 0 | 2012-04-19T17:29:57.017000-04:00 | |
| 1240271 | C2 GROUP, LLC 75bab424-2202-4433-9039-1450730b184c | Q1 | C2 GROUP, LLC | 66693 | AMERICAS HEALTH INSURANCE PLANS (AHIP) | 2012 | first_quarter | PHA | H.R. 3988, Generic Drug and Biosimilar User Fee Act (Murphy/Pitts/Waxman) - FDA user fee programs. S. 2193, Ensuring Safe Medical Devices for Patients (Merkley) - FDA oversight of medical devices. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2012-04-19T17:39:22.257000-04:00 | |
| 1240309 | GEPHARDT GROUP GOVERNMENT AFFAIRS fd3354ee-a3b9-4c95-92e9-cf13441c89db | Q1 | GEPHARDT GROUP GOVERNMENT AFFAIRS | 315717 | HEALIANCE PHARMACEUTICALS | 2012 | first_quarter | PHA | innovative diabetes treatment | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2012-04-19T17:42:58.710000-04:00 | |
| 1240345 | EMPIRE CONSULTING GROUP 6a159745-801c-4032-a168-f8dcd87ca12b | Q1 | EMPIRE CONSULTING GROUP | 400703105 | PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 2012 | first_quarter | PHA | H.R. 3995, Protecting Consumer Access to Generic Drugs Act; The Prescription Drug User Fee Act ("PDUFA V"); Prescription Drug Abuse; H.R. 452, Medicare Decisions Accountability Act (repealing provisions of healthcare law relating to the Independent Payment Advisory Board/IPAB); S.1002/H.R. 4223, Safe Doses Act; and Biologics Price Competition Act implementation; | HOUSE OF REPRESENTATIVES | 30000 | 0 | 0 | 2012-04-19T17:46:13.663000-04:00 | |
| 1240582 | C2 GROUP, LLC 24fcf0e2-f29b-4f44-bf3c-97b9197383ea | Q1 | C2 GROUP, LLC | 66693 | PERRIGO INC | 2012 | first_quarter | PHA | OTC medication eligibility under Flexible Spending Accounts, S.312/H.R.605, The Patients' Freedom to Choose Act; Drug Regulation; FDA reform; PDUFA, H.R.3630. Pharmaceutical traceability. Rx OTC switch. Rx TEC. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2012-04-19T18:14:07.643000-04:00 | |
| 1240754 | BLUESTONE STRATEGIES, LLC cb8dfe19-f911-48b3-8a67-186cca41eb1c | Q1 | BLUESTONE STRATEGIES, LLC | 400658980 | PHARMACEUTICAL CARE MANAGEMENT ASSOCIATION (PCMA) | 2012 | first_quarter | PHA | Pharmacy Act; Drug Reimportation;Generic Brand Settlement; Generic Dispensing; Generic Biologics; and Specialty Drug Issues. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2012-04-19T18:43:46.780000-04:00 | |
| 1240761 | DENTONS US LLP 3a354d52-f2f7-4de6-9615-4d5e84c6d2ea | Q1 | DENTONS US LLP | 36105 | AMERISOURCEBERGEN | 2012 | first_quarter | PHA | H.R. 1483, H.R. 3026, & S. 1584 - Pharmaceutical pedigree anti-counterfeiting; H.R. 2245, S. 296. - drug shortages | HOUSE OF REPRESENTATIVES,SENATE | 40000 | 0 | 0 | 2012-04-19T18:45:22.123000-04:00 | |
| 1240970 | KAISER FOUNDATION HEALTH PLAN INC. caef8063-2c13-4eb6-acee-a0bb3f404257 | Q1 | KAISER FOUNDATION HEALTH PLAN INC. | 21027 | KAISER FOUNDATION HEALTH PLAN INC | 2012 | first_quarter | PHA | HR 4095 - Online Pharmacy Safety Act: To amend the Federal Food, Drug, and Cosmetic Act to improve the safety of Internet pharmacies. Sponsor: Cassidy (R-LA) | Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,SENATE | 190000 | 0 | 0 | 2012-04-19T19:55:52.820000-04:00 | |
| 1241006 | PODESTA GROUP, INC. 515e56d6-d2b9-4101-aeb4-7357e450ea90 | Q1 | PODESTA GROUP, INC. | 31680 | BRISTOL-MYERS SQUIBB | 2012 | first_quarter | PHA | Prescription Drug User Fee Act reauthorization. FDA issues. Diabetes drugs issues. | HOUSE OF REPRESENTATIVES,SENATE | 50000 | 0 | 0 | 2012-04-19T20:08:09.230000-04:00 | |
| 1241036 | PODESTA GROUP, INC. d013a39e-93ab-4d11-b2ec-aedb2f63cc0c | Q1 | PODESTA GROUP, INC. | 31680 | GENZYME | 2012 | first_quarter | PHA | Prescription Drug User Fee Act reauthorization. Pub. L. 111-148, Patient Protection and Affordable Care Act (implementation). Pub. L. 111-152, Health Care and Education Reconciliation Act of 2010 (implementation). Product exclusivity issues. | HOUSE OF REPRESENTATIVES,SENATE | 60000 | 0 | 0 | 2012-04-19T20:17:22.563000-04:00 |
Advanced export
JSON shape: default, array, newline-delimited, object
CREATE TABLE lobbying_activities (
id INTEGER PRIMARY KEY,
filing_uuid TEXT NOT NULL,
filing_type TEXT NOT NULL,
registrant_name TEXT NOT NULL,
registrant_id INTEGER,
client_name TEXT NOT NULL,
filing_year INTEGER NOT NULL,
filing_period TEXT NOT NULL,
issue_code TEXT,
specific_issues TEXT,
government_entities TEXT,
income_amount INTEGER,
expense_amount INTEGER,
is_no_activity INTEGER DEFAULT 0,
is_termination INTEGER DEFAULT 0,
received_date TEXT,
CONSTRAINT fk_activity_filing FOREIGN KEY (filing_uuid)
REFERENCES lobbying_filings_raw(filing_uuid)
);
CREATE INDEX idx_act_client_name ON lobbying_activities(client_name COLLATE NOCASE);
CREATE INDEX idx_act_issue_code ON lobbying_activities(issue_code);
CREATE INDEX idx_act_filing_year ON lobbying_activities(filing_year);
CREATE INDEX idx_act_filing_uuid ON lobbying_activities(filing_uuid);